CytoDyn Inc. Conversion of Stock, Amount Issued
CytoDyn Inc. (CYDY) reported Conversion of Stock, Amount Issued of $2.00 thousand for the 9-month period ending 2022-02-28, per its 10-Q filed 2022-04-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountIssued1 · last filed 2022-04-11
- CytoDyn Inc. conversion of stock, amount issued for the quarter ending 2021-11-30 was $1.00K.
- CytoDyn Inc. conversion of stock, amount issued for the quarter ending 2020-08-31 was $9.54M, a 848.96% increase year-over-year.
- CytoDyn Inc. conversion of stock, amount issued for the quarter ending 2020-05-31 was $4.12M, a 182.98% increase year-over-year.
- CytoDyn Inc. conversion of stock, amount issued for the quarter ending 2020-02-29 was $9.29M, a 2042139.12% increase year-over-year.
- CytoDyn Inc. conversion of stock, amount issued for fiscal 2020 was $14.94M, a 926.68% increase from fiscal 2019.
- CytoDyn Inc. conversion of stock, amount issued for fiscal 2019 was $1.46M, a 74.86% decline from fiscal 2018.
- CytoDyn Inc. conversion of stock, amount issued for fiscal 2018 was $5.79M.
- CytoDyn Inc. conversion of stock, amount issued for fiscal 2017 was $0.00.
| Period end | Conversion of Stock, Amount Issued 3 month | Conversion of Stock, Amount Issued 6 month | Conversion of Stock, Amount Issued 9 month | Conversion of Stock, Amount Issued 9 month as first filed | Conversion of Stock, Amount Issued 12 month | Conversion of Stock, Amount Issued 12 month as first filed |
|---|---|---|---|---|---|---|
| 2022-02-28 | $2.00K 10-Q · filed 2022-04-11 | |||||
| 2021-11-30 | $1.00K 10-Q · filed 2022-04-11 | |||||
| 2020-08-31 | $9.54M 10-Q · filed 2020-10-09 | $13.65M derived: sum of 2 quarters · filed 2020-10-09 | $22.95M derived: sum of 3 quarters · filed 2020-10-09 | $23.47M derived: sum of 4 quarters · filed 2020-10-09 | ||
| 2020-05-31 | $4.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $13.41M derived: sum of 2 quarters · filed 2020-08-14 | $13.93M derived: sum of 3 quarters · filed 2020-08-14 | $14.94M 10-K · filed 2020-08-14 | ||
| 2020-02-29 | $9.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-09 | $9.82M derived: sum of 2 quarters · filed 2020-04-09 | $10.82M 10-Q · filed 2020-04-09 | $12.28M derived: sum of 4 quarters · filed 2020-10-09 | ||
| 2019-11-30 | $525.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-09 | $1.53M 10-Q · filed 2020-01-09 | $2.98M derived: sum of 3 quarters · filed 2020-10-09 | $2.98M derived: sum of 4 quarters · filed 2020-10-09 | ||
| 2019-08-31 | $1.00M 10-Q · filed 2020-10-09 | $2.46M derived: sum of 2 quarters · filed 2020-10-09 | $2.46M derived: sum of 3 quarters · filed 2020-10-09 | $2.46M derived: sum of 4 quarters · filed 2020-10-09 | ||
| 2019-05-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $1.46M derived: sum of 2 quarters · filed 2020-08-14 | $1.46M derived: sum of 3 quarters · filed 2020-08-14 | $1.46M 10-K · filed 2020-08-14 | ||
| 2019-02-28 | $455.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-09 | $455.00 derived: sum of 2 quarters · filed 2020-04-09 | $455.00 10-Q · filed 2020-04-09 | $455.00K 10-Q · filed 2019-04-09 | $5.79M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2018-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-09 | $0.00 10-Q · filed 2020-01-09 | $5.79M derived: sum of 3 quarters · filed 2020-08-14 | |||
| 2018-08-31 | $0.00 10-Q · filed 2019-10-08 | $5.79M derived: sum of 2 quarters · filed 2020-08-14 | ||||
| 2018-05-31 | $5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $5.79M 10-K · filed 2020-08-14 | $0.00 10-K · filed 2019-08-14 | |||
| 2018-02-28 | $0.00 10-Q · filed 2019-04-09 | |||||
| 2017-05-31 | $0.00 10-K · filed 2019-08-14 |